This randomized, placebo-controlled, double-blind trial examined pharmacokinetics, pharmacodynamics, and safety in healthy adults aged 2161
To understand how the blend functions, it helps to break down each constituent compound: Mod GRF 1-29 (Modified GRF 1-29): This is a 29-amino acid peptide that mimics the natural Growth Hormone Releasing Hormone (GHRH)
Weight loss peptides (GLP-1 agonists) Examples : Semaglutide, Tirzepatide, Liraglutide Common side effects (mostly GI-related): Nausea : Frequency: 40-50% of users initially Severity: Mild to moderate Duration: Usually 1-3 weeks (improves with continued use) Management: Start low dose, increase gradually, eat smaller meals Constipation : Frequency: 20-30% of users Severity: Mild to moderate Management: Increase fiber, water, consider stool softener Diarrhea : Frequency: 15-20% of users Severity: Mild Duration: Usually temporary Management: Probiotics, reduce fatty foods Fatigue : Frequency: 20-30% initially Severity: Mild to moderate Duration: 2-4 weeks (improves as caloric deficit stabilizes) Management: Adequate protein, electrolytes, patience Reduced appetite (intended effect): Not a side effect - this is the mechanism Goal: 15-20% reduction in caloric intake Result: Weight loss Read our semaglutide vs tirzepatide comparison
Why Ipamorelin Is the Perfect GHRP Partner The reason I recommend Ipamorelin specifically as the GHRP in this stack, rather than GHRP-6 or GHRP-2, comes down to one word: Selectivity
Greg Fahy has shown patients supplementing with hGH are able to rejuvenate their thymus gland
